Andrea De Luca
About
Andrea De Luca is a scholar working on Infectious Diseases, Virology and Epidemiology.
According to data from OpenAlex, Andrea De Luca has authored 345 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 230 papers in Infectious Diseases, 185 papers in Virology and 100 papers in Epidemiology. Recurrent topics in Andrea De Luca's work include HIV/AIDS drug development and treatment (189 papers), HIV Research and Treatment (185 papers) and HIV/AIDS Research and Interventions (132 papers). Andrea De Luca is often cited by papers focused on HIV/AIDS drug development and treatment (189 papers), HIV Research and Treatment (185 papers) and HIV/AIDS Research and Interventions (132 papers). Andrea De Luca collaborates with scholars based in Italy, United States and United Kingdom. Andrea De Luca's co-authors include Andrea Antinori, Antonella Cingolani, Adriana Ammassari, Rita Murri, Roberto Cauda, Simona Di Giambenedetto, Antonella d’Arminio Monforte, David M. Simpson, David B. Clifford and Enrica Tamburrini and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.
In The Last Decade
Andrea De Luca
340 papers receiving 9.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Andrea De Luca Italy | 50 | 5.1k | 4.0k | 2.7k | 1.8k | 1.3k | 345 | 9.5k | ||
| Andrea Antinori Italy | 64 | 9.9k 1.9× | 7.4k 1.8× | 4.1k 1.6× | 2.0k 1.1× | 3.0k 2.3× | 561 | 15.4k | ||
| Jan Gerstoft Denmark | 48 | 4.8k 0.9× | 3.6k 0.9× | 3.0k 1.1× | 990 0.6× | 3.1k 2.4× | 303 | 9.2k | ||
| Court Pedersen Denmark | 48 | 3.6k 0.7× | 2.8k 0.7× | 3.4k 1.3× | 722 0.4× | 2.3k 1.8× | 226 | 8.5k | ||
| Niels Obel Denmark | 47 | 4.3k 0.8× | 2.3k 0.6× | 3.2k 1.2× | 783 0.4× | 2.6k 2.0× | 317 | 8.4k | ||
| Matthias Cavassini Switzerland | 58 | 7.8k 1.5× | 5.0k 1.2× | 3.7k 1.4× | 935 0.5× | 3.0k 2.3× | 367 | 11.8k | ||
| Rajesh T. Gandhi United States | 46 | 5.5k 1.1× | 4.2k 1.1× | 2.3k 0.9× | 873 0.5× | 1.1k 0.8× | 164 | 9.8k | ||
| Juan Berenguer Spain | 58 | 3.4k 0.7× | 1.1k 0.3× | 7.0k 2.6× | 1.2k 0.7× | 1.1k 0.8× | 467 | 13.7k | ||
| Peré Domingo Spain | 51 | 5.2k 1.0× | 3.8k 0.9× | 2.3k 0.9× | 557 0.3× | 3.1k 2.4× | 392 | 9.5k | ||
| Adriano Lazzarin Italy | 70 | 12.2k 2.4× | 10.9k 2.7× | 6.2k 2.4× | 1.9k 1.0× | 3.4k 2.6× | 616 | 20.6k | ||
| Giovanni Guaraldi Italy | 46 | 4.0k 0.8× | 1.9k 0.5× | 3.1k 1.2× | 512 0.3× | 4.1k 3.2× | 407 | 9.4k |
Countries citing papers authored by Andrea De Luca
Since
Specialization
Citations
This map shows the geographic impact of Andrea De Luca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea De Luca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea De Luca more than expected).
Fields of papers citing papers by Andrea De Luca
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Andrea De Luca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea De Luca. The network helps show where Andrea De Luca may publish in the future.
Co-authorship network of co-authors of Andrea De Luca
This figure shows the co-authorship network connecting the top 25 collaborators of Andrea De Luca. A scholar is included among the top collaborators of Andrea De Luca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea De Luca. Andrea De Luca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sarfo, Fred Stephen, Barbara Castelnuovo, Iuri Fanti, et al.. (2019). Longer-term effectiveness of protease-inhibitor-based second line antiretroviral therapy in four large sub-Saharan African clinics. Journal of Infection. 78(5). 402–408.
2.
Baldin, Gianmaria, Arturo Ciccullo, Amedeo Capetti, et al.. (2018). Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF ) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV ‐infected patients in clinical practice: results from a multicentre, observational study. HIV Medicine. 20(2). 164–168.
3.
Mussini, Cristina, P Lorenzini, Massimo Puoti, et al.. (2015). Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus. PLoS ONE. 10(12). e0140877–e0140877.
4.
Rossetti, Barbara, Cláudia Bianco, Bianca Bruzzone, et al.. (2013). Virological and Immunological Response to Antiretroviral Regimens Containing Maraviroc in HIV Type 1-Infected Patients in Clinical Practice: Role of Different Tropism Testing Results and of Concomitant Treatments. AIDS Research and Human Retroviruses. 30(1). 17–24.
5.
Marazzi, Maria Cristina, Leonardo Palombi, P Scarcella, et al.. (2013). Predictors of Adverse Outcomes in HIV-1–infected Children Receiving Combination Antiretroviral Treatment. The Pediatric Infectious Disease Journal. 33(3). 295–300.
6.
Marzocchetti, Angela, Jessica Schwarz, Simona Di Giambenedetto, et al.. (2011). The Effect of Polymorphisms in Candidate Genes on the Long-Term Risk of Lipodystrophy and Dyslipidemia in HIV-Infected White Patients Starting Antiretroviral Therapy. AIDS Research and Human Retroviruses. 27(12). 1299–1309.
7.
Vandamme, Anne–Mieke, Ricardo Camacho, Francesca Ceccherini‐Silberstein, et al.. (2011). European recommendations for the clinical use of HIV drug resistance testing: 2011 update.. PubMed. 13(2). 77–108.
8.
Tordato, Federica, Alessandro Cozzi Lepri, Paola Cicconi, et al.. (2010). Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure*. HIV Medicine. 12(1). 4–13.
9.
Müller, Viktor, Fredy Suter, Nicoletta Ladisa, et al.. (2009). Increasing Clinical Virulence in Two Decades of the Italian HIV Epidemic. PLoS Pathogens. 5(5). e1000454–e1000454.
10.
Grob, Dieter, François Porchet, Frank Kleinstück, et al.. (2009). A comparison of outcomes of cervical disc arthroplasty and fusion in everyday clinical practice: surgical and methodological aspects. European Spine Journal. 19(2). 297–306.
11.
Bracciale, Laura, Simona Di Giambenedetto, Manuela Colafigli, et al.. (2009). Virological Suppression Reduces Clinical Progression in Patients with Multiclass-Resistant HIV Type 1. AIDS Research and Human Retroviruses. 25(3). 261–267.
12.
Prosperi, Mattia, Iuri Fanti, Giovanni Ulivi, et al.. (2009). Robust Supervised and Unsupervised Statistical Learning for HIV Type 1 Coreceptor Usage Analysis. AIDS Research and Human Retroviruses. 25(3). 305–314.
13.
Palombi, Leonardo, Maria Cristina Marazzi, Giovanni Guidotti, et al.. (2008). Incidence and Predictors of Death, Retention, and Switch to Second‐Line Regimens in Antiretroviral‐Treated Patients in Sub‐Saharan African Sites with Comprehensive Monitoring Availability. Clinical Infectious Diseases. 48(1). 115–122.
14.
Giambenedetto, Simona Di, Manuela Colafigli, Carmela Pinnetti, et al.. (2008). Genotypic Resistance Profile and Clinical Progression of Treatment-Experienced HIV Type 1-Infected Patients with Virological Failure. AIDS Research and Human Retroviruses. 24(2). 149–154.
15.
Ammassari, Adriana, Alessandro Cozzi‐Lepri, Carlo Torti, et al.. (2007). Treatment complexity and risk of virological rebound in persons receiving cART. UCL Discovery (University College London).
16.
Luca, Andrea De. (2006). The impact of resistance on viral fitness and its clinical implications. 21(3). 273–5.
17.
Marzocchetti, Angela, Antonella Cingolani, Simona Di Giambenedetto, et al.. (2005). Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome–associated progressive multifocal leukoencephalopathy. Journal of NeuroVirology. 11(2). 219–224.
18.
Antinori, Andrea, Mauro Zaccarelli, Antonella Cingolani, et al.. (2002). Cross-Resistance among Nonnucleoside Reverse Transcriptase Inhibitors Limits Recycling Efavirenz after Nevirapine Failure. AIDS Research and Human Retroviruses. 18(12). 835–838.
19.
Perno, Carlo Federico, Francesca Ceccherini‐Silberstein, Andrea De Luca, et al.. (2002). Virologic Correlates of Adherence to Antiretroviral Medications and Therapeutic Failure. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31. S118–S122.
20.
Luca, Andrea De, Maria Letizia Giancola, Antonella Cingolani, et al.. (2000). Circulating Levels and ex Vivo Production of β-Chemokines, Interferon γ, and Interleukin 2 in Advanced Human Immunodeficiency Virus Type 1 Infection: The Effect of Protease Inhibitor Therapy. AIDS Research and Human Retroviruses. 16(9). 835–843.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Andrea Antinori Breakdown of academic impact, for papers by Jan Gerstoft Breakdown of academic impact, for papers by Court Pedersen Breakdown of academic impact, for papers by Niels Obel Breakdown of academic impact, for papers by Matthias Cavassini Breakdown of academic impact, for papers by Rajesh T. Gandhi Breakdown of academic impact, for papers by Juan Berenguer Breakdown of academic impact, for papers by Peré Domingo Breakdown of academic impact, for papers by Adriano Lazzarin Breakdown of academic impact, for papers by Giovanni Guaraldi